MedPath
FDA Approval

Cefprozil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 8, 2010
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Cefprozil(250 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefprozil

Product Details

NDC Product Code
54868-5757
Application Number
ANDA065261
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 8, 2010
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CefprozilActive
Code: 4W0459ZA4VClass: ACTIBQuantity: 250 mg in 5 mL
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
ASPARTAMEInactive
Code: Z0H242BBR1Class: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
GLYCINEInactive
Code: TE7660XO1CClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
CARBOXYMETHYLCELLULOSE SODIUMInactive
Code: K679OBS311Class: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
© Copyright 2025. All Rights Reserved by MedPath